SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    N. Ford, Z. Shubber, A. Calmy, C. Irvine, C. Rapparini, O. Ajose, R. L. Beanland, M. Vitoria, M. Doherty, K. H. Mayer, Choice of Antiretroviral Drugs for Postexposure Prophylaxis for Adults and Adolescents: A Systematic Review, Clinical Infectious Diseases, 2015, 60, suppl 3, S170

    CrossRef

  2. 2
    N. Ford, F. Venter, C. Irvine, R. L. Beanland, Z. Shubber, Starter Packs Versus Full Prescription of Antiretroviral Drugs for Postexposure Prophylaxis: A Systematic Review, Clinical Infectious Diseases, 2015, 60, suppl 3, S182

    CrossRef

  3. 3
    J McAllister, P Read, A McNulty, WWY Tong, A Ingersoll, A Carr, Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence, HIV Medicine, 2014, 15, 1
  4. 4
    Wenlong Huang, Margarita Calvo, Kersti Karu, Hans R. Olausen, Gabriella Bathgate, Kenji Okuse, David L.H. Bennett, Andrew S.C. Rice, A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy, Pain, 2013, 154, 4, 560

    CrossRef

  5. 5
    Eric Ouattara, Christine Danel, Raoul Moh, Delphine Gabillard, Gilles Peytavin, Romuald Konan, Jérome Le Carrou, Franck Bohoussou, Serge P Eholie, Xavier Anglaret, Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts, Journal of the International AIDS Society, 2013, 16, 1

    CrossRef

  6. 6
    Franziska Denk, Wenlong Huang, Ben Sidders, Angela Bithell, Megan Crow, John Grist, Simone Sharma, Daniel Ziemek, Andrew S.C. Rice, Noel J. Buckley, Stephen B. McMahon, HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain, Pain, 2013, 154, 9, 1668

    CrossRef

  7. 7
    Chad M Centner, Kathleen J Bateman, Jeannine M Heckmann, Manifestations of HIV infection in the peripheral nervous system, The Lancet Neurology, 2013, 12, 3, 295

    CrossRef

  8. 8
    Trine Gulholm, Salina Jamani, I. Mary Poynten, David J. Templeton, Non-occupational HIV post-exposure prophylaxis at a Sydney metropolitan sexual health clinic, Sexual Health, 2013, 10, 5, 438

    CrossRef

  9. 9
    Olajumoke Oshinaike, Akinsegun Akinbami, Oluwadamilola Ojo, Anthonia Ogbera, Njideka Okubadejo, Frank Ojini, Mustapha Danesi, Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy, AIDS Research and Treatment, 2012, 2012, 1

    CrossRef

  10. 10
    John McAllister, Andrew Carr, Should a protease inhibitor be standard of care for HIV postexposure prophylaxis?, AIDS, 2011, 25, 5, 721

    CrossRef

  11. 11
    Gerard J. B. Sonder, Jan M. Prins, Rosa M. Regez, Kees Brinkman, Jan-Willem Mulder, Jan Veenstra, Frans A. P. Claessen, Anneke van den Hoek, Comparison of Two HIV Postexposure Prophylaxis Regimens Among Men Who Have Sex With Men in Amsterdam: Adverse Effects Do Not Influence Compliance, Sexually Transmitted Diseases, 2010, 37, 11, 681

    CrossRef

  12. 12
    Tristan J Barber, Paul D Benn, Postexposure prophylaxis for HIV following sexual exposure, Current Opinion in HIV and AIDS, 2010, 5, 4, 322

    CrossRef

  13. 13
    I Mary Poynten, Fengyi Jin, Limin Mao, Garrett P Prestage, Susan C Kippax, John M Kaldor, John Imrie, Andrew E Grulich, Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men, AIDS, 2009, 23, 9, 1119

    CrossRef

  14. 14
    Cynthia L. Gay, Angela D. Kashuba, Myron S. Cohen, HIV Prevention, 2009,

    CrossRef

  15. 15
    Cynthia L. Gay, Myron S. Cohen, Antiretrovirals to prevent HIV infection: Pre-and postexposure prophylaxis, Current Infectious Disease Reports, 2008, 10, 4, 323

    CrossRef

  16. 16
    Kenneth H Mayer, Matthew J Mimiaga, Daniel Cohen, Chris Grasso, Ronn Bill, Rodney VanDerwarker, Alvan Fisher, Tenofovir DF Plus Lamivudine or Emtricitabine for Nonoccupational Postexposure Prophylaxis (NPEP) in a Boston Community Health Center, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2008, 47, 4, 494

    CrossRef

  17. 17
    E. Hamlyn, P. Easterbrook, Occupational exposure to HIV and the use of post-exposure prophylaxis, Occupational Medicine, 2007, 57, 5, 329

    CrossRef

  18. 18
    Prasanna Jagannathan, Raphael Landovitz, Michelle E Roland, Postexposure prophylaxis after sexual exposure to HIV, Future HIV Therapy, 2007, 1, 1, 35

    CrossRef

  19. 19
    Michelle E Roland, Postexposure prophylaxis after sexual exposure to HIV, Current Opinion in Infectious Diseases, 2007, 20, 1, 39

    CrossRef

  20. 20
    K Smyth, JS Affandi, JC McArthur, C Bowtell-Harris, AM Mijch, K Watson, K Costello, IJ Woolley, P Price, SL Wesselingh, CL Cherry, Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993–2006, HIV Medicine, 2007, 8, 6
  21. 21
    IM Poynten, DE Smith, DA Cooper, JM Kaldor, AE Grulich, The public health impact of widespread availability of nonoccupational postexposure prophylaxis against HIV, HIV Medicine, 2007, 8, 6
  22. 22
    Viviana Simon, David D Ho, Quarraisha Abdool Karim, HIV/AIDS epidemiology, pathogenesis, prevention, and treatment, The Lancet, 2006, 368, 9534, 489

    CrossRef